Entity Details

Primary name EPT1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9C0D9
EntryNameEPT1_HUMAN
FullNameEthanolaminephosphotransferase 1
TaxID9606
Evidenceevidence at protein level
Length397
SequenceStatuscomplete
DateCreated2003-08-22
DateModified2021-06-02

Ontological Relatives

GenesSELENOI

GO terms

Show/Hide Table
GOName
GO:0004307 ethanolaminephosphotransferase activity
GO:0005789 endoplasmic reticulum membrane
GO:0005794 Golgi apparatus
GO:0006646 phosphatidylethanolamine biosynthetic process
GO:0016021 integral component of membrane
GO:0046872 metal ion binding

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000462 CDP-alcohol phosphatidyltransferaseFamilyFamily
IPR014472 Choline/ethanolamine phosphotransferaseFamilyFamily
IPR043130 CDP-alcohol phosphotransferase, transmembrane domainFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618768 OMIMSpastic paraplegia 81, autosomal recessive (SPG81)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG81 is a complicated form characterized by white matter abnormalities, hypomyelination with progressive white matter loss, delayed motor development, progressive spasticity, and impaired intellectual development and speech delay. Additional features may include bifid uvula, microcephaly, seizures, and variable ocular anomalies. The disease is caused by variants affecting the gene represented in this entry.

Interactions

5 interactions